29
Fri, Mar
51 New Articles

Moral & Partners and Acar & Ergonen Advise on Taxim Capital Investment in Moltek

Moral & Partners and Acar & Ergonen Advise on Taxim Capital Investment in Moltek

Turkiye
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Moral & Partners has advised Turkish private equity fund Taxim Capital on its investment in Moltek A.S. through Luxembourg subsidiary LuxTheranostics. Acar & Ergonen advised Moltek’s shareholders.

Financial details were not disclosed.

Moltek is a Turkish radiopharmaceuticals producer established in 2007. It specializes in nuclear medicine and its products are used in oncology, neurology, and cardiology.

The Moral & Partners team was led by Partners Resat Moral and Serkan Pamukkale and included Senior Associates Karaca Kacar, Serra Haviyo, and Duygu Bozkurt and Associate Dilara Kaymaz.

The Acar & Ergonen team included Partners Duygu Acar Yucesoy and Asli Tezcan and Associates Beyza Akinci and Pinar Akkaya.

Our Latest Issue